149 related articles for article (PubMed ID: 21481176)
1. Successful long-term replacement therapy with FXIII concentrate (Fibrogammin(®) P) for severe congenital factor XIII deficiency: a prospective multicentre study.
Dreyfus M; Barrois D; Borg JY; Claeyssens S; Torchet MF; Arnuti B; Pautard B;
J Thromb Haemost; 2011 Jun; 9(6):1264-6. PubMed ID: 21481176
[No Abstract] [Full Text] [Related]
2. Corifact™/Fibrogammin® P in the prophylactic treatment of hereditary factor XIII deficiency: results of a prospective, multicenter, open-label study.
Nugent D
Thromb Res; 2012 Dec; 130 Suppl 2():S12-4. PubMed ID: 23439001
[TBL] [Abstract][Full Text] [Related]
3. [Congenital factor XIII deficiency required high-dose factor XIII concentrate in late pregnancy].
Takahashi T; Hatao K; Suzukawa M; Oji T
Rinsho Ketsueki; 2007 May; 48(5):418-20. PubMed ID: 17571589
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic therapy with Fibrogammin P is associated with a decreased incidence of bleeding episodes: a retrospective study.
Lusher J; Pipe SW; Alexander S; Nugent D
Haemophilia; 2010 Mar; 16(2):316-21. PubMed ID: 20017752
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of prophylactic treatment with plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
Ashley C; Chang E; Davis J; Mangione A; Frame V; Nugent DJ
Haemophilia; 2015 Jan; 21(1):102-8. PubMed ID: 25377187
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and safety of plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
Nugent DJ; Ashley C; García-Talavera J; Lo LC; Mehdi AS; Mangione A
Haemophilia; 2015 Jan; 21(1):95-101. PubMed ID: 25458735
[TBL] [Abstract][Full Text] [Related]
7. Long-term prophylaxis in patients with severe congenital factor XIII deficiency is not complicated by inhibitor formation.
Naderi M; Ahmadinejad M; Hosseini MS; Moradi E; Dorgalaleh A; Shamsizadeh M
Blood Coagul Fibrinolysis; 2017 Jun; 28(4):276-278. PubMed ID: 27306330
[TBL] [Abstract][Full Text] [Related]
8. Use of Factor XIII (FXIII) concentrate in patients with congenital FXIII deficiency undergoing surgical procedures.
Janbain M; Nugent DJ; Powell JS; St-Louis J; Frame VB; Leissinger CA
Transfusion; 2015 Jan; 55(1):45-50. PubMed ID: 25070582
[TBL] [Abstract][Full Text] [Related]
9. A large case series on surgical outcomes in congenital factor XIII deficiency patients in Iran.
Naderi M; Haghpanah S; Miri-Aliabad G; Tavosi H; Karimi M
J Thromb Haemost; 2017 Dec; 15(12):2300-2305. PubMed ID: 29028293
[TBL] [Abstract][Full Text] [Related]
10. Clinical manifestations and management of life-threatening bleeding in the largest group of patients with severe factor XIII deficiency.
Naderi M; Dorgalaleh A; Alizadeh S; Tabibian S; Hosseini S; Shamsizadeh M; Bamedi T
Int J Hematol; 2014 Nov; 100(5):443-9. PubMed ID: 25230816
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the FXIII deficiency prophylaxis intervals in large number of FXIII deficiency patients from Iran.
Naderi M; Eshghi P; Cohan N; Haghpanah S; Karimi M
Haemophilia; 2013 May; 19(3):e175-6. PubMed ID: 23510337
[No Abstract] [Full Text] [Related]
12. Prophylaxis in rare coagulation disorders -- factor XIII deficiency.
Nugent DJ
Thromb Res; 2006; 118 Suppl 1():S23-8. PubMed ID: 16616323
[TBL] [Abstract][Full Text] [Related]
13. Factor XIII Deficiency.
Karimi M; Bereczky Z; Cohan N; Muszbek L
Semin Thromb Hemost; 2009 Jun; 35(4):426-38. PubMed ID: 19598071
[TBL] [Abstract][Full Text] [Related]
14. A child with acquired factor XIII deficiency: case report and literature review.
Kessel R; Hu C; Shore-Lesserson L; Rand J; Manwani D
Haemophilia; 2013 Nov; 19(6):814-26. PubMed ID: 23607876
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of recombinant factor XIII in young children with congenital FXIII deficiency and comparison with older patients.
Williams M; Will A; Stenmo C; Rosholm A; Tehranchi R
Haemophilia; 2014 Jan; 20(1):99-105. PubMed ID: 23834599
[TBL] [Abstract][Full Text] [Related]
16. Congenital factor XIII deficiency in Switzerland: from the worldwide first case in 1960 to its molecular characterisation in 2005.
Schroeder V; Durrer D; Meili E; Schubiger G; Kohler HP
Swiss Med Wkly; 2007 May; 137(19-20):272-8. PubMed ID: 17594539
[TBL] [Abstract][Full Text] [Related]
17. Recombinant factor XIII prophylaxis is safe and effective in young children with congenital factor XIII-A deficiency: international phase 3b trial results.
Kerlin BA; Inbal A; Will A; Williams M; Garly ML; Jacobsen L; Kearney SL
J Thromb Haemost; 2017 Aug; 15(8):1601-1606. PubMed ID: 28581691
[TBL] [Abstract][Full Text] [Related]
18. Congenital factor XIII deficiency with treatment of factor XIII concentrate and normal vaginal delivery.
Kobayashi T; Terao T; Kojima T; Takamatsu J; Kamiya T; Saito H
Gynecol Obstet Invest; 1990; 29(3):235-8. PubMed ID: 2358199
[TBL] [Abstract][Full Text] [Related]
19. Successful pregnancy in a woman with congenital factor XIII deficiency treated with substitutive therapy. Report of a second case.
Rodeghiero F; Castaman GC; Di Bona E; Ruggeri M; Dini E
Blut; 1987 Jul; 55(1):45-8. PubMed ID: 3607295
[TBL] [Abstract][Full Text] [Related]
20. Intracranial hemorrhage in congenital deficiency of factor XIII.
Abbondanzo SL; Gootenberg JE; Lofts RS; McPherson RA
Am J Pediatr Hematol Oncol; 1988; 10(1):65-8. PubMed ID: 3189718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
